8-K: Aveanna Refinances Debt, Boosts Liquidity

Aveanna Healthcare Holdings Inc. successfully refinanced its first lien credit facility, extending maturities and increasing revolving credit availability to $250 million while repaying its second lien debt.

Summary

• Aveanna Healthcare LLC, a wholly owned subsidiary of Aveanna Healthcare Holdings Inc., entered into the fourth joinder and twelfth amendment to its First Lien Credit Agreement on September 17, 2025.
• The refinancing replaced the existing $885,950,000 senior secured term loan facility and the $170,330,000 senior secured revolving credit facility.
• The new 2025 Refinancing Revolving Credit Facility provides total aggregate revolving loan commitments of $250,000,000, an increase of $79,670,000.
• The 2025 Refinancing Term Loans and an incremental senior secured term loan facility (2025 Incremental Term Facility) combine for a total principal balance of $1,325,000,000.
• The maturity date for the 2025 Refinancing Revolving Credit Facility is September 17, 2030, and for the 2025 Refinancing Term Facility is September 17, 2032.
• Proceeds from the 2025 Term Loans were used to fully refinance the existing first lien term loans and the $415,000,000 Second Lien Term Loan, pay accrued interest, and fund working capital and general corporate purposes.
• The Second Lien Credit Agreement, dated December 10, 2021, was terminated on September 17, 2025, following the repayment of its $415.0 million term loan.
• Loans under the 2025 Term Loans bear interest at Term SOFR plus 3.75% per annum or a base rate plus 2.75% per annum.
• Loans under the 2025 Refinancing Revolving Credit Facility bear interest at Term SOFR plus 3.75% per annum or a base rate plus 2.75% per annum, with potential step-downs of 0.25% and 0.50% based on the Consolidated First Lien Net Leverage Ratio.
• The 2025 Refinancing Term Facility amortizes at a rate of 1.00% per annum, payable quarterly, and was issued with an original issue discount at 99.75% of par.
• A commitment fee of 0.50% per annum applies to the undrawn portion of the 2025 Refinancing Revolving Credit Facility, subject to step-downs to 0.375% and 0.250%.

Sentiment

Score: 8

Explanation: The refinancing significantly improves Aveanna's debt maturity profile and liquidity, eliminating the second lien debt and providing greater financial flexibility. Management's comments are highly positive, indicating strong confidence in the company's operational performance and strategic execution. The terms, including interest rate margins and fees, appear to be in line with market conditions for such facilities, and the extension of maturities is a clear positive for long-term stability.

Positives

• Extended the maturity date of the revolving credit facility from 2028 to September 17, 2030, providing longer-term liquidity.
• Extended the maturity date of the first lien term loans to September 17, 2032, improving the company's debt maturity profile.
• Increased total aggregate revolving loan commitments from $170.3 million to $250.0 million, enhancing available liquidity.
• Repaid the entire $415.0 million Second Lien Term Loan, simplifying the capital structure and reducing interest expense associated with junior debt.
• Management expressed confidence that the refinancing strengthens the balance sheet and enhances the ability to execute on strategy, reflecting strong operating performance and financing partner support.

Negatives

• The 2025 Refinancing Term Facility was issued with an original issue discount at 99.75% of par, indicating a slight upfront cost.
• A prepayment premium of 1.00% applies to 2025 Term Loans if prepaid or amended to decrease the Effective Yield on or prior to March 17, 2026, unless in connection with a Qualifying IPO, Change of Control, or Transformative Acquisition.

Risks

• The Consolidated First Lien Net Leverage Ratio covenant must not exceed 8.00 to 1.00 as of the last day of any Test Period, which, if breached, could trigger an Event of Default for revolving credit lenders (though subject to a cure right).
• Potential for a 1.00% prepayment premium on 2025 Term Loans if a repricing transaction occurs before March 17, 2026, which could impact future refinancing flexibility.

Future Outlook

Management anticipates that the successful refinancing will strengthen the company's balance sheet and enhance its ability to execute on its strategic initiatives, supporting continued growth and expansion.

Management Comments

• Matt Buckhalter, Chief Financial Officer, stated: "This refinancing marks another important milestone in the company's continued momentum. By extending maturities and increasing our available liquidity, including our undrawn revolving facility, we have strengthened our balance sheet and enhanced our ability to execute on our strategy. This progress reflects the strong operating performance we've delivered and the confidence our financing partners have in our business."
• Jeff Shaner, CEO, commented: "This successful refinancing reflects our operating performance and the proven value of our national home care platform. We are grateful to our capital partners for their unwavering support of our mission and their commitment to our continued growth and expansion."

Industry Context

The successful refinancing, coupled with management's comments on the 'proven value of our national home care platform,' suggests a positive outlook for Aveanna Healthcare within the broader home care industry. This indicates that the company is well-positioned to capitalize on industry trends, such as increasing demand for home-based healthcare services, and maintain its competitive standing.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess against global benchmarks. However, the ability to secure an upsized revolving credit facility and extend maturities for both term loans and revolving credit facilities in the current market environment generally indicates strong lender confidence, which is a positive signal relative to industry peers facing tighter credit conditions.

Stakeholder Impact

• Shareholders: Benefit from reduced financial risk due to extended debt maturities and increased liquidity, potentially leading to improved share price stability and growth prospects.
• Creditors (Lenders): The refinancing demonstrates continued confidence from financing partners, with new and extended facilities, while the repayment of the second lien improves the first lien's position.
• Employees: A stronger financial position can provide greater stability and resources for the company, potentially supporting job security and future growth initiatives.
• Customers: Enhanced financial stability may enable the company to continue investing in and expanding its healthcare services, benefiting patients and their families.

Next Steps

• Continue to execute on the company's strategy, leveraging the strengthened balance sheet and enhanced liquidity.
• Pursue continued growth and expansion, supported by the improved financial position.

Key Dates

Recommendation

The successful debt refinancing significantly de-risks Aveanna's balance sheet by extending maturities and eliminating the second lien debt. The increased revolving credit facility provides substantial liquidity, enhancing financial flexibility for strategic initiatives and operational needs. This move is a strong positive signal to the market, indicating robust lender confidence and a strengthened foundation for future growth. While there's a minor original issue discount and a potential prepayment premium, the overall benefits of improved capital structure and liquidity outweigh these factors, making the stock an attractive 'buy' for long-term investors.

Keywords

Aveanna Healthcare, AVAH, Debt Refinancing, Credit Facility, Term Loans, Revolving Credit, Second Lien, Liquidity, Maturity Extension, Financial Restructuring, Healthcare Services